NDC00597-0031-12: CLONIDINE TRANSDERMAL SYSTEM.
The CLONIDINE TRANSDERMAL SYSTEM is a the manufacturer industrial component. Key specifications include usual_dose: 0.1 MG RELEASED PER DAYY FOR 7 DAYS, features_provided: BANDAGE, ADHESIVE, NONSENSITIZED, overall_strength_in_system: 2.55 MG CLONIDINE ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: CLONIDINE TRANSDERMAL SYSTEM 2.5MG ADHESIVE BANDAGE 12S. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-224-3319, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| usual_dose | 0.1 MG RELEASED PER DAYY FOR 7 DAYS |
| special_features | A TRANSDERMAL RESERVOIR SYSTEM W/A MICROPORUS POLYPROPYLENE MEMBRANE THAT CONTROLS THE RATE OF DELIVERY OF CLONIDINE FROM THE SYSTEM TO THE SKIN SURFACE; W/12 ADHESIVE OVERLAYS |
| features_provided | BANDAGE, ADHESIVE, NONSENSITIZED |
| overall_strength_in_system | 2.55 MG CLONIDINE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | CLONIDINE TRANSDERMAL SYSTEM 2.5MG ADHESIVE BANDAGE 12S |
| NSN | 6505-01-224-3319 |
| USUAL DOSE | 0.1 MG RELEASED PER DAYY FOR 7 DAYS |
| FEATURES PROVIDED | BANDAGE, ADHESIVE, NONSENSITIZED |
| OVERALL STRENGTH IN SYSTEM | 2.55 MG CLONIDINE ACTIVE INGREDIENT |
| SPECIAL FEATURES | A TRANSDERMAL RESERVOIR SYSTEM W/A MICROPORUS POLYPROPYLENE MEMBRANE THAT CONTROLS THE RATE OF DELIVERY OF CLONIDINE FROM THE SYSTEM TO THE SKIN SURFACE; W/12 ADHESIVE OVERLAYS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CLONIDINE TRANSDERMAL SYSTEM 2.5MG ADHESIVE BANDAGE 12S |